A Study to Evaluate Efficacy and Safety of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate (MTX) Treatment
Clinical trial NCT02305849 · COMPLETED
Trial details
- NCT number
- NCT02305849
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-25
- Primary completion
- 2017-06-20
- Enrollment
- 519
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.